• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

RHEUMATOID ARTHRITIS FOXP3 AUTOPHAGY IFNG ERBB-2 IL17A IL23A LISTERIA MONOCYTOGENES PSEUDOMONAS AERUGINOSA APOPTOTIC PROCESS STREPTOCOCCUS PNEUMONIAE ALZHEIMER'S DISEASE CANCER IL6 CELL DEATH METFORMIN REMICADE HELICOBACTER PYLORI DIABETES MELLITUS ESCHERICHIA COLI PORPHYROMONAS GINGIVALIS NEURODEGENERATIVE DISORDERS SOD1 CELL DIFFERENTIATION INSULIN INFLAMMATION ANGIOGENESIS CD4 IMMUNE RESPONSE DOXORUBICIN TH17 CELLS AGING RECEPTOR CELL PROLIFERATION TNF 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CTLA4 CELL DIVISION CLOSTRIDIUM DIFFICILE CANDIDA ALBICANS PARKINSON DISEASE STAPHYLOCOCCUS AUREUS CASP3 BREAST CANCER TP53

© 2020 Biovista Vizit All Rights Reserved.